InfuSystem Holdings (INFU) Net Income towards Common Stockholders (2010 - 2026)
InfuSystem Holdings' (INFU) quarterly Net Income towards Common Stockholders came in at $1.0 million in Q1 2026, up 562.27% YoY from $153562.1 in Q1 2025, and down 50.68% on a QoQ basis from $2.1 million in Q4 2025.
InfuSystem Holdings (INFU) Net Income towards Common Stockholders (2010 - 2026) Analysis & Trends
InfuSystem Holdings (INFU) has 17 years of Net Income towards Common Stockholders data on file, last reported at $1.0 million in Q1 2026.
- Quarterly Net Income towards Common Stockholders rose 562.27% year-over-year to $1.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $7.9 million (up 147.29% YoY) and the FY2025 annual result came in at $6.6 million, up 182.6% from the prior year.
- Net Income towards Common Stockholders slipped to $1.0 million in Q1 2026, from $2.1 million in the prior quarter.
- In the past five years, Net Income towards Common Stockholders ranged from a high of $2.6 million in Q2 2025 to a low of -$1.1 million in Q1 2024.
- A 5-year average of $652235.3 and a median of $443000.0 in 2022 frame the typical range for Net Income towards Common Stockholders.
- The widest YoY moves for Net Income towards Common Stockholders: up 884.38% in 2024, down 266.0% in 2024.
- Tracing INFU's Net Income towards Common Stockholders over 5 years: stood at $138000.0 in 2022, then tumbled by 30.43% to $96000.0 in 2023, then jumped by 884.38% to $945000.0 in 2024, then surged by 118.2% to $2.1 million in 2025, then sank by 50.68% to $1.0 million in 2026.
- The last three Net Income towards Common Stockholders figures came in at $1.0 million (Q1 2026), $2.1 million (Q4 2025), and $2.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 1.28 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 907.00 Mn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 241.40 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 249.10 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 574.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 621.86 Mn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 201.00 Mn |
| 10 | InfuSystem Holdings | 244.67 Mn | 243.70 Mn | 21.41 Mn | 3.26 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.26 Mn |
| Mar 31, 2026 | 1.02 Mn |
| Dec 31, 2025 | 2.06 Mn |
| Sep 30, 2025 | 2.26 Mn |
| Jun 30, 2025 | 2.60 Mn |
| Mar 31, 2025 | -220,000.00 |
| Dec 31, 2024 | 945,000.00 |
| Sep 30, 2024 | 1.79 Mn |
| Jun 30, 2024 | 700,000.00 |
| Mar 31, 2024 | -1.10 Mn |
| Dec 31, 2023 | 96,000.00 |
| Sep 30, 2023 | 720,000.00 |
| Jun 30, 2023 | 435,000.00 |
| Mar 31, 2023 | -300,000.00 |
| Dec 31, 2022 | 138,000.00 |
| Sep 30, 2022 | 443,000.00 |
| Jun 30, 2022 | -164,000.00 |
| Mar 31, 2022 | -330,000.00 |
| Dec 31, 2021 | 387,000.00 |
| Sep 30, 2021 | -448,000.00 |